Tirzepatide Leads to Long-Term Glucose Control and Weight Loss in Type 2 Diabetes
Research highlights the sustained effects of tirzepatide on glucose control and weight loss over a two-year period.
Topline:
A new study from the SURPASS-4 trial reveals that tirzepatide helps maintain glucose control and weight loss for up to two years in patients with type 2 diabetes. Approximately 80% of participants who initially achieved glycemic control or weight loss at 52 weeks maintained these improvements at 104 weeks.
Study Details:
The SURPASS-4 trial focuse…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.